This federal Project Grant award, totaling $1,330,652, was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The grant will fund a hybrid type-1 effectiveness-implementation trial of the "Motivation Matters!" mHealth intervention to support early antiretroviral therapy (ART) adherence in HIV-positive African women engaged in sex work. The key products and services to be delivered include: 1) a randomized controlled...
The National Institute of Mental Health (NIMH) awarded a $183,331 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The Regents of the University of California, San Francisco (UCSF) on August 27, 2024. This 5-year grant supports research to examine the influence of migration-driven social support network dynamics and characteristics on HIV testing and treatment engagement among African American women migrants. The study aims to develop, implement, and evaluate a...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $3,640,897 to The Regents of the University of California, San Francisco (UCSF) to assess the effects of a multisectoral climate-smart agricultural intervention on the reproductive and sexual health of adolescent girls and young women in Kenya. The primary objective is to evaluate the impact of the "Shamba Maisha" (SM) intervention,...
The National Institute of Mental Health (NIMH) awarded a 5-year, $197,035 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The grant aims to design and evaluate a community-based intervention to engage men who use alcohol and substances in HIV prevention services in rural South Africa. Key products/services to be delivered include: Conducting qualitative research to explore the...
The National Institute of Mental Health (NIMH) awarded a $653,677 Project Grant (CFDA 93.242 Mental Health Research Grants) to the University of California, Los Angeles (UCLA) to implement a cluster randomized control trial (CRCT) to test the impact of a long-term, dynamic choice intervention on 12-month viral suppression among HIV patients experiencing repeated and prolonged treatment interruptions in Malawi. This 5-year research project, titled "ONGOING DYNAMIC CHOICE TO ADDRESS HIV...
The National Institute of Mental Health (NIMH) awarded a $665,225 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The Washington University in St. Louis to conduct the "SUUBI4PREP: Improving PrEP Access and Adherence among Adolescent Girls and Young Women in Uganda" research project. The project aims to examine the impact of a multilevel intervention combining HIV risk reduction counseling, peer support for PrEP initiation and adherence, and economic empowerment...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to adapt and evaluate the effectiveness of the Comprehensive Adherence Resource and Empowerment Support (CARES) intervention to increase pre-exposure prophylaxis (PrEP) continuation and adherence among adolescent girls and young women in South Africa and Zimbabwe. The total funding amount is $710,187, with an award date of September 11, 2024 and an...
The University of South Florida (USF) received a $389,527 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) to conduct a study examining strategies and contextual factors that optimize the delivery of pre-exposure prophylaxis (PrEP) for HIV prevention in Kenya. The key products and services to be delivered through this two-year project include: Identifying implementation strategies and contextual factors that...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $2,856,918 to evaluate the efficacy of an enhanced problem-solving therapy intervention to improve perinatal depression and engagement in HIV care among women living with HIV in Malawi. The project aims to assess the intervention's impact on perinatal mental health, HIV care engagement, and infant health outcomes through a randomized...
This $715,041 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to understand real-world choices, preferences, and outcomes related to the roll-out of oral and long-acting injectable PrEP (pre-exposure prophylaxis) among women in Malawi. The study, titled "Better Info on Women's PrEP Choices and Outcomes in Malawi", has three specific aims: 1) Evaluate longitudinal patterns of oral...
The National Institute of Mental Health (NIMH) awarded a Project Grant (CFDA 93.242 - Mental Health Research Grants) totaling $707,796 to the Regents of the University of California, San Francisco (UCSF) to build on the success of the "Malkia Klabu" (MK) loyalty program and evaluate strategies for scaling the program's HIV prevention services for adolescent girls and young women (AGYW) in sub-Saharan Africa.
The key products and services to be delivered under this grant include: 1) Testing the adoption and continuation of the MK program in control and intervention drug shops currently enrolled in an ongoing effectiveness trial, 2) Phasing out subsidies for HIV self-test (HIVST) kit procurement by drug shops over 36 months to assess the sustainability of the MK program under different HIVST kit subsidy levels and reimbursement models, and 3) Conducting mixed-methods research to assess implementation, fidelity, receptivity, behavior change pathways, and motivational contexts for shopkeeper engagement. The ultimate goal is to inform the Ministry of Health and Pharmacy Council partners on the optimal strategies for scaling the MK program to provide AGYW-friendly HIV prevention services through drug vendors.